nodes	percent_of_prediction	percent_of_DWPC	metapath
Clotrimazole—ABCC3—Vincristine—lymphatic system cancer	0.158	0.178	CbGbCtD
Clotrimazole—ABCC3—Methotrexate—lymphatic system cancer	0.0958	0.107	CbGbCtD
Clotrimazole—CYP1A2—Carmustine—lymphatic system cancer	0.0829	0.093	CbGbCtD
Clotrimazole—ABCC2—Vincristine—lymphatic system cancer	0.0719	0.0807	CbGbCtD
Clotrimazole—CYP2E1—Mitoxantrone—lymphatic system cancer	0.0674	0.0756	CbGbCtD
Clotrimazole—CYP2C19—Teniposide—lymphatic system cancer	0.0604	0.0677	CbGbCtD
Clotrimazole—CYP2C9—Teniposide—lymphatic system cancer	0.0502	0.0563	CbGbCtD
Clotrimazole—CYP3A7—Vincristine—lymphatic system cancer	0.048	0.0539	CbGbCtD
Clotrimazole—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.048	0.0539	CbGbCtD
Clotrimazole—ABCC2—Methotrexate—lymphatic system cancer	0.0436	0.0489	CbGbCtD
Clotrimazole—ABCB1—Mitoxantrone—lymphatic system cancer	0.0341	0.0382	CbGbCtD
Clotrimazole—CYP3A4—Cytarabine—lymphatic system cancer	0.0296	0.0332	CbGbCtD
Clotrimazole—CYP3A4—Teniposide—lymphatic system cancer	0.0292	0.0327	CbGbCtD
Clotrimazole—ABCB1—Vincristine—lymphatic system cancer	0.0234	0.0263	CbGbCtD
Clotrimazole—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0204	0.0229	CbGbCtD
Clotrimazole—ABCB1—Methotrexate—lymphatic system cancer	0.0142	0.0159	CbGbCtD
Clotrimazole—CYP3A4—Vincristine—lymphatic system cancer	0.014	0.0158	CbGbCtD
Clotrimazole—Localized exfoliation—Bleomycin—lymphatic system cancer	0.00894	0.0824	CcSEcCtD
Clotrimazole—Blister—Mechlorethamine—lymphatic system cancer	0.00703	0.0648	CcSEcCtD
Clotrimazole—Dermatitis bullous—Mechlorethamine—lymphatic system cancer	0.00385	0.0355	CcSEcCtD
Clotrimazole—Burning sensation—Carmustine—lymphatic system cancer	0.00303	0.0279	CcSEcCtD
Clotrimazole—Abdominal cramps—Vincristine—lymphatic system cancer	0.00297	0.0274	CcSEcCtD
Clotrimazole—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00256	0.0236	CcSEcCtD
Clotrimazole—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00255	0.0235	CcSEcCtD
Clotrimazole—Liver function test abnormal—Teniposide—lymphatic system cancer	0.0025	0.0231	CcSEcCtD
Clotrimazole—Cystitis noninfective—Bleomycin—lymphatic system cancer	0.00235	0.0217	CcSEcCtD
Clotrimazole—Cystitis—Bleomycin—lymphatic system cancer	0.00232	0.0214	CcSEcCtD
Clotrimazole—Skin exfoliation—Bleomycin—lymphatic system cancer	0.0023	0.0212	CcSEcCtD
Clotrimazole—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.0022	0.0203	CcSEcCtD
Clotrimazole—Bladder pain—Bleomycin—lymphatic system cancer	0.00218	0.0201	CcSEcCtD
Clotrimazole—Skin exfoliation—Carmustine—lymphatic system cancer	0.00201	0.0185	CcSEcCtD
Clotrimazole—Haemoglobin—Teniposide—lymphatic system cancer	0.00189	0.0174	CcSEcCtD
Clotrimazole—Haemorrhage—Teniposide—lymphatic system cancer	0.00188	0.0173	CcSEcCtD
Clotrimazole—Haemoglobin—Fludarabine—lymphatic system cancer	0.00166	0.0153	CcSEcCtD
Clotrimazole—Haemorrhage—Fludarabine—lymphatic system cancer	0.00165	0.0152	CcSEcCtD
Clotrimazole—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00141	0.013	CcSEcCtD
Clotrimazole—Burning sensation—Methotrexate—lymphatic system cancer	0.0014	0.0129	CcSEcCtD
Clotrimazole—Oedema—Teniposide—lymphatic system cancer	0.00133	0.0123	CcSEcCtD
Clotrimazole—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.00131	0.0121	CcSEcCtD
Clotrimazole—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00128	0.0118	CcSEcCtD
Clotrimazole—Haemoglobin—Bleomycin—lymphatic system cancer	0.00122	0.0112	CcSEcCtD
Clotrimazole—Haemorrhage—Bleomycin—lymphatic system cancer	0.00121	0.0111	CcSEcCtD
Clotrimazole—Oedema—Fludarabine—lymphatic system cancer	0.00117	0.0108	CcSEcCtD
Clotrimazole—Vomiting—Mechlorethamine—lymphatic system cancer	0.00115	0.0106	CcSEcCtD
Clotrimazole—Rash—Mechlorethamine—lymphatic system cancer	0.00114	0.0105	CcSEcCtD
Clotrimazole—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00114	0.0105	CcSEcCtD
Clotrimazole—Nausea—Mechlorethamine—lymphatic system cancer	0.00107	0.0099	CcSEcCtD
Clotrimazole—Haemoglobin—Carmustine—lymphatic system cancer	0.00106	0.00978	CcSEcCtD
Clotrimazole—Urticaria—Teniposide—lymphatic system cancer	0.00106	0.00976	CcSEcCtD
Clotrimazole—Haemorrhage—Carmustine—lymphatic system cancer	0.00106	0.00973	CcSEcCtD
Clotrimazole—Abdominal pain—Teniposide—lymphatic system cancer	0.00105	0.00971	CcSEcCtD
Clotrimazole—Erythema—Bleomycin—lymphatic system cancer	0.00105	0.0097	CcSEcCtD
Clotrimazole—Pain—Fludarabine—lymphatic system cancer	0.001	0.00923	CcSEcCtD
Clotrimazole—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000986	0.00909	CcSEcCtD
Clotrimazole—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000981	0.00904	CcSEcCtD
Clotrimazole—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.000951	0.00876	CcSEcCtD
Clotrimazole—Cystitis—Methotrexate—lymphatic system cancer	0.00094	0.00866	CcSEcCtD
Clotrimazole—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000929	0.00857	CcSEcCtD
Clotrimazole—Erythema—Carmustine—lymphatic system cancer	0.000919	0.00847	CcSEcCtD
Clotrimazole—Bladder pain—Methotrexate—lymphatic system cancer	0.00088	0.00811	CcSEcCtD
Clotrimazole—Oedema—Bleomycin—lymphatic system cancer	0.000859	0.00792	CcSEcCtD
Clotrimazole—Erythema—Mitoxantrone—lymphatic system cancer	0.000854	0.00787	CcSEcCtD
Clotrimazole—Vomiting—Teniposide—lymphatic system cancer	0.000848	0.00781	CcSEcCtD
Clotrimazole—Rash—Teniposide—lymphatic system cancer	0.000841	0.00775	CcSEcCtD
Clotrimazole—Dermatitis—Teniposide—lymphatic system cancer	0.00084	0.00774	CcSEcCtD
Clotrimazole—Nausea—Teniposide—lymphatic system cancer	0.000792	0.0073	CcSEcCtD
Clotrimazole—Oedema—Carmustine—lymphatic system cancer	0.00075	0.00691	CcSEcCtD
Clotrimazole—Vomiting—Fludarabine—lymphatic system cancer	0.000745	0.00687	CcSEcCtD
Clotrimazole—Rash—Fludarabine—lymphatic system cancer	0.000739	0.00681	CcSEcCtD
Clotrimazole—Dermatitis—Fludarabine—lymphatic system cancer	0.000738	0.0068	CcSEcCtD
Clotrimazole—Pain—Bleomycin—lymphatic system cancer	0.000735	0.00677	CcSEcCtD
Clotrimazole—Oedema—Vincristine—lymphatic system cancer	0.000716	0.0066	CcSEcCtD
Clotrimazole—Oedema—Mitoxantrone—lymphatic system cancer	0.000697	0.00643	CcSEcCtD
Clotrimazole—Nausea—Fludarabine—lymphatic system cancer	0.000696	0.00641	CcSEcCtD
Clotrimazole—Urticaria—Bleomycin—lymphatic system cancer	0.000682	0.00629	CcSEcCtD
Clotrimazole—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000652	0.00601	CcSEcCtD
Clotrimazole—Pain—Carmustine—lymphatic system cancer	0.000641	0.00591	CcSEcCtD
Clotrimazole—Pain—Vincristine—lymphatic system cancer	0.000612	0.00564	CcSEcCtD
Clotrimazole—Pain—Mitoxantrone—lymphatic system cancer	0.000596	0.00549	CcSEcCtD
Clotrimazole—Abdominal pain—Carmustine—lymphatic system cancer	0.000593	0.00546	CcSEcCtD
Clotrimazole—Abdominal pain—Vincristine—lymphatic system cancer	0.000566	0.00522	CcSEcCtD
Clotrimazole—Urticaria—Mitoxantrone—lymphatic system cancer	0.000554	0.0051	CcSEcCtD
Clotrimazole—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000551	0.00508	CcSEcCtD
Clotrimazole—Vomiting—Bleomycin—lymphatic system cancer	0.000546	0.00503	CcSEcCtD
Clotrimazole—Rash—Bleomycin—lymphatic system cancer	0.000542	0.00499	CcSEcCtD
Clotrimazole—Dermatitis—Bleomycin—lymphatic system cancer	0.000541	0.00499	CcSEcCtD
Clotrimazole—Nausea—Bleomycin—lymphatic system cancer	0.00051	0.0047	CcSEcCtD
Clotrimazole—Haemoglobin—Methotrexate—lymphatic system cancer	0.000491	0.00453	CcSEcCtD
Clotrimazole—Haemorrhage—Methotrexate—lymphatic system cancer	0.000489	0.00451	CcSEcCtD
Clotrimazole—Vomiting—Carmustine—lymphatic system cancer	0.000477	0.00439	CcSEcCtD
Clotrimazole—Rash—Carmustine—lymphatic system cancer	0.000473	0.00436	CcSEcCtD
Clotrimazole—Dermatitis—Carmustine—lymphatic system cancer	0.000472	0.00435	CcSEcCtD
Clotrimazole—Vomiting—Vincristine—lymphatic system cancer	0.000455	0.00419	CcSEcCtD
Clotrimazole—Rash—Vincristine—lymphatic system cancer	0.000451	0.00416	CcSEcCtD
Clotrimazole—Dermatitis—Vincristine—lymphatic system cancer	0.000451	0.00416	CcSEcCtD
Clotrimazole—Nausea—Carmustine—lymphatic system cancer	0.000445	0.00411	CcSEcCtD
Clotrimazole—Vomiting—Mitoxantrone—lymphatic system cancer	0.000443	0.00409	CcSEcCtD
Clotrimazole—Rash—Mitoxantrone—lymphatic system cancer	0.00044	0.00405	CcSEcCtD
Clotrimazole—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000439	0.00405	CcSEcCtD
Clotrimazole—Erythema—Methotrexate—lymphatic system cancer	0.000426	0.00392	CcSEcCtD
Clotrimazole—Nausea—Vincristine—lymphatic system cancer	0.000425	0.00392	CcSEcCtD
Clotrimazole—Nausea—Mitoxantrone—lymphatic system cancer	0.000414	0.00382	CcSEcCtD
Clotrimazole—Pain—Methotrexate—lymphatic system cancer	0.000297	0.00274	CcSEcCtD
Clotrimazole—Urticaria—Methotrexate—lymphatic system cancer	0.000276	0.00254	CcSEcCtD
Clotrimazole—Abdominal pain—Methotrexate—lymphatic system cancer	0.000275	0.00253	CcSEcCtD
Clotrimazole—Vomiting—Methotrexate—lymphatic system cancer	0.000221	0.00204	CcSEcCtD
Clotrimazole—Rash—Methotrexate—lymphatic system cancer	0.000219	0.00202	CcSEcCtD
Clotrimazole—Dermatitis—Methotrexate—lymphatic system cancer	0.000219	0.00202	CcSEcCtD
Clotrimazole—Nausea—Methotrexate—lymphatic system cancer	0.000206	0.0019	CcSEcCtD
